1. Ahmad, M., Zeitlin, I. J., and Parratt, J. R., The release of kininase from rat isolated hearts during myocardial ischaemia.Immunopharmacol., 33, 299–300 (1996).
2. Bhoola, K. D., Figueroa, C. D., and Worthy, K., Bioregulation of kinins, kallikrein, kininogens, and kininases.Pharmacol. Rev., 44(1), 1–80 (1992).
3. Campbell, J. D., Anastasopoulos, F., Duncan, M. A., James, M. G., Kladis, A., and Briscoe, A. T., Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.J. Pharmacol. Exper. Therapeut., 287(2), 567–577 (1998).
4. Dendorfer, A., Wolfrum, S., Wellhoner, P., Korsman, K., and Dominaik, P., Intravascular and interstitial degradation of bradykinin in isolated rat heart.Br. J. Pharmacol., 122, 1179–1187 (1997).
5. Dumoulin, J. M., Adam, A., Rouleau, L. J., and Lamontagne, D., Comparison of a vasopeptidase inhibitor with neutral endopeptidase and angiotensin-converting enzyme inhibitors on bradykinin metabolism in the rat coronary bed.J. Cardiovasc. Pharmacol., 37, 359–366 (2001).